2025-07-25T06:54:59-05:00 2024-12-31 042571780 AAFCPAS INC 50 WASHINGTON STREET WESTBOROUGH MA 01581 990 2024-01-01 043150037 THE BOSTON FOUNDATION FOR SIGHT INC BOST 7817267337 464 HILLSIDE AVENUE 205 NEEDHAM MA 02494 CHERYL SADELI CHIEF FINANCIAL OFFICER 7817267337 2025-07-24 1 1 CAITLIN LIMOGES CPA P01633588 5083669100 2025-07-24 2024 2025-03-06 01:10:19Z BOSTONSIGHT SARA YOST 464 HILLSIDE AVENUE 205 NEEDHAM MA 02494 6318864 0 X WWW.BOSTONSIGHT.ORG X 1992 MA BOSTON FOUNDATION FOR SIGHT, D/B/A BOSTONSIGHT, IS A WORLD RENOWNED NONPROFIT EYE HEALTH CARE ORGANIZATION. OUR MISSION IS TO IMPROVE QUALITY OF LIFE BY TRANSFORMING THE UNDERSTANDING, TREATMENT, AND CARE OF THE OCULAR SURFACE. WE ACHIEVED THIS THROUGH FIVE KEY STRATEGIES: PUBLIC AND PROFESSIONAL EDUCATION; CLINICAL RESEARCH; PATIENT ENGAGEMENT AND EMPOWERMENT; SPECIALIZED MEDICAL TREATMENT; AND TECHNICAL INNOVATION. 8 7 59 7 42000 30050 444630 346596 5311899 5724988 76173 99276 129708 148004 5962410 6318864 0 0 0 0 4118992 4175502 0 0 54036 1904177 1784606 6023169 5960108 -60759 358756 10737439 10568283 4857268 4336492 5880171 6231791 X OUR MISSION IS TO IMPROVE QUALITY OF LIFE BY TRANSFORMING THE UNDERSTANDING, TREATMENT, AND CARE OF THE OCULAR SURFACE. 0 0 4105753 5591873 BOSTON FOUNDATION FOR SIGHT, D/B/A BOSTONSIGHT, IS A WORLD RENOWNED NONPROFIT EYE HEALTH CARE ORGANIZATION. OUR MISSION IS TO IMPROVE QUALITY OF LIFE BY TRANSFORMING THE UNDERSTANDING, TREATMENT, AND CARE OF THE OCULAR SURFACE. SINCE 1992 WE HAVE RESTORED SIGHT TO THOUSANDS OF PATIENTS FROM AROUND THE WORLD. PROSTHETIC REPLACEMENT OF THE OCULAR SURFACE ECOSYSTEM (PROSE) IS AN INTEGRATED AND ITERATIVE TREATMENT PIONEERED BY BOSTONSIGHT THAT RESTORES VISUAL FUNCTION, SUPPORTS HEALING, REDUCES SYMPTOMS AND IMPROVES QUALITY OF LIFE FOR PATIENTS SUFFERING WITH OCULAR SURFACE DISEASE. BOSTONSIGHT PROSE USES FDA CLEARED CUSTOM DESIGNED AND FABRICATED PROSTHETIC DEVICES TO REPLACE OR SUPPORT IMPAIRED OCULAR SURFACE SYSTEM FUNCTIONS. 375188 42788 BOSTONSIGHT'S CLINICAL EXPERIENCE IN OCULAR SURFACE DISEASE CREATES THE NECESSARY FOUNDATION FOR DRIVING RESEARCH AND ULTIMATELY INNOVATION IN THE DESIGN AND APPLICATION OF SCLERAL LENSES FOR IMPROVING QUALITY OF LIFE FOR PATIENTS AROUND THE WORLD. THE ORGANIZATION'S PROSPECTIVE CLINICAL RESEARCH PROGRAM IS UNIQUE AS WE DRAW FROM OUR HISTORY OF DIRECT PATIENT CARE, AIMING TO SOLVE NEW CLINICAL CHALLENGES WITH DIRECT IN-HOUSE ACCESS TO ENGINEERING, SOFTWARE DESIGN AND OUR STATE-OF-THE-ART MANUFACTURING FACILITY. IN 2018, BOSTONSIGHT WAS NAMED THE NUMBER ONE CONTRIBUTOR TO SCLERAL LENS PEER-REVIEWED PUBLICATIONS; AND IN 2021, AN ANALYSIS IN CONTACT LENS AND ANTERIOR EYE LISTED BOSTONSIGHT AS THE MOST IMPACTFUL INSTITUTION IN SCLERAL LENS PUBLICATIONS. 160399 49180 ONE OF BOSTONSIGHT'S CORE VALUES IS TO EXPAND KNOWLEDGE AND EDUCATION TO EMPOWER PRACTITIONERS TO ELEVATE THE STANDARD OF CARE FOR PATIENTS. WE BELIEVE BY SHARING KNOWLEDGE, WE WILL MOVE THE INDUSTRY FORWARD. OPTOMETRISTS AND OPHTHALMOLOGISTS WORLDWIDE HAVE COME TO BOSTONSIGHT FOR IN-PERSON EDUCATION AT OUR CLINIC. THIS HAS RANGED FROM CLINICAL ROTATIONS TO RESEARCH OPPORTUNITIES TO COMPLETING OUR INTENSIVE PROSE CLINICAL TRAINING PROGRAM, WHICH ADDRESSES THE MOST ADVANCED CASES OF OCULAR SURFACE DISEASES. FITACADEMY EVENTS ARE SOME OF BOSTONSIGHT'S MOST RECOGNIZED EDUCATIONAL PROGRAMS. FITACADEMY OFFERS OPTOMETRISTS EXPERT TRAINING IN FITTING AND HANDLING SCLERAL LENSES IN BOTH A DIDACTIC AND EXPERIENTIAL SETTING. THE TRAINING COMBINES BOSTONSIGHT'S 30 YEARS OF CLINICAL EXPERIENCE WITH THE EXPERTISE OF THE INDUSTRY'S TOP PROFESSIONALS. BEGINNING IN 2024, WE COLLABORATED WITH OUR PARTNERS IN LATIN AMERICA AND HELD OUR FIRST GLOBAL EDUCATION PROGRAM. 4641340 1 1 0 0 0 0 0 0 0 1 1 0 0 1 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 1 14 0 1 59 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 8 7 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 MA X CHERYL SADELI 7817267337 464 HILLSIDE AVE SUITE 205 NEEDHAM MA 02494 SARA YOST PRESIDENT & CEO 40.00 X X 341143 0 35212 PAMELA J ANDERSON ESQ BOARD CHAIR 0.25 X X 0 0 0 MARCUS HUGHES ESQ DIRECTOR 0.25 X 0 0 0 HOWARD PURCELL OD DIRECTOR 0.25 X 0 0 0 MICHAEL RAIZMAN MD DIRECTOR 0.25 X 0 0 0 RON REMY DIRECTOR 0.25 X 0 0 0 CLIFFORD SCOTT OD DIRECTOR 0.25 X 0 0 0 DONNA DESMOND DIRECTOR 0.25 X 0 0 0 LAUREL VILLERS CLERK, CHIEF BUSINESS DEVELOPMENT OFFICER 40.00 X 211641 0 31111 CHERYL SADELI CFO/TREASURER 40.00 X 188513 0 10752 DANIEL BROCKS MD MD, CHIEF MEDICAL OFFICER 40.00 X 334887 0 36052 KAREN CARRASQUILLO OD PHD SVP OF CLINICAL & PROF AFFAIRS 40.00 X 237288 0 30943 KLIMENTY LEVIN SOFTWARE ARCHITECT 40.00 X 187969 0 10436 ALAN KWOK OPTOMETRIST 40.00 X 163841 0 29270 BITA ASGHARI OPTOMETRIST 40.00 X 154493 0 8600 CHIRAG PATEL OPTOMETRIST 40.00 X 146118 0 15105 OLGA TOMASHEVSKAYA DIRECTOR OF ENGINEERING 40.00 X 142712 0 8751 2108605 0 216232 16 0 1 0 RSM US LLP 80 CITY SQUARE BOSTON MA 02129 SOFTWARE DEVELOPMENT AND IT CONSULTING 364187 1 109565 237031 62242 346596 PATIENT SERVICES, NET 621110 3993501 3993501 NETWORK CLINIC REVENUE 621110 1639544 1597544 42000 SPONSORSHIP AND EDUCAT 621110 49180 49180 RESEARCH STUDY REVENUE 621110 42763 42763 5724988 99276 99276 147151 147151 OTHER REVENUE 900099 853 853 853 6318864 5683841 42000 246427 1457542 916603 508046 32893 2244334 2035015 208276 1043 78538 72599 5775 164 145358 56973 87993 392 249730 205654 41880 2196 18372 10607 7765 78600 78600 120750 108150 12529 71 8582 8582 276137 235222 34330 6585 71420 61543 9500 377 91386 51892 37354 2140 52109 52109 45865 45865 499438 494862 4370 206 78596 53141 25391 64 SUPPLIES 230879 230879 OTHER EXPENSES 129346 55674 67711 5961 SERVICE FEES 61846 417 59485 1944 PERMITS, LICENSES AND F 21280 21280 5960108 4641340 1264732 54036 219859 298958 2543240 2424686 1240201 1164732 423243 386043 97363 100038 8170177 5261553 2347525 2908624 3866008 3285202 10737439 10568283 816272 809497 589672 560041 724685 518071 2726639 2448883 4857268 4336492 X 5673282 6021081 206889 210710 5880171 6231791 10737439 10568283 358756 -7136 0 X X 0 1 X 1 0 X 1160076 1466279 352253 444630 346596 3769834 1160076 1466279 352253 444630 346596 3769834 393578 3376256 61896 79736 116340 196321 246427 700720 30153 33666 63819 18395 9560 853 28808 4563181 25068989 0.73990 0.69010 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: OTHER INCOME - 2022 AMOUNT: $ 18,395. 2023 AMOUNT: $ 9,560. 2024 AMOUNT: $ 853. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 185000 185000 185000 185000 185000 185000 185000 185000 185000 185000 1.00000 0 0 432413 207015 225398 7727729 5048983 2678746 10035 5555 4480 2908624 DUE FROM AFFILIATE 1008436 DEPOSITS 32762 RIGHT-OF-USE ASSETS -OPERATING 2244004 3285202 OPERATING LEASE LIABILITIES 2448883 2448883 X PART V, LINE 4: THE ENDOWMENT IS SOLELY USED TO SUPPORT PATIENT SERVICES. PART X, LINE 2: BOSTONSIGHT ACCOUNTS FOR UNCERTAINTY IN INCOME TAXES IN ACCORDANCE WITH ASC TOPIC 740, INCOME TAXES. THIS STANDARD CLARIFIES THE ACCOUNTING FOR UNCERTAINTY IN TAX POSITIONS AND PRESCRIBES A RECOGNITION THRESHOLD AND MEASUREMENT ATTRIBUTE FOR THE FINANCIAL STATEMENTS REGARDING A TAX POSITION TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. BOSTONSIGHT HAS DETERMINED THAT THERE ARE NO UNCERTAIN TAX POSITIONS WHICH QUALIFY FOR EITHER RECOGNITION OR DISCLOSURE IN THE COMBINED FINANCIAL STATEMENTS AT DECEMBER 31, 2024. BOSTONSIGHT HAS IDENTIFIED ITS TAX STATUS AS A TAX EXEMPT ENTITY AND ITS DETERMINATION OF WHICH ACTIVITIES ARE RELATED AND UNRELATED AS ITS ONLY SIGNIFICANT TAX POSITIONS AND HAS DETERMINED THAT SUCH TAX POSITIONS DO NOT RESULT IN AN UNCERTAINTY REQUIRING RECOGNITION. BOSTONSIGHT IS NOT CURRENTLY UNDER EXAMINATION BY ANY TAXING JURISDICTION. FEDERAL AND STATE INCOME TAX RETURNS ARE GENERALLY OPEN FOR EXAMINATION FOR THREE YEARS FOLLOWING THE DATE FILED. X 0 0 X X 0 0 0 0 0 0 0 1 0 SARA YOST PRESIDENT & CEO 335143 0 6000 0 0 0 13800 0 21412 0 376355 0 0 0 DANIEL BROCKS MD MD, CHIEF MEDICAL OFFICER 328887 0 6000 0 0 0 13740 0 22312 0 370939 0 0 0 KAREN CARRASQUILLO OD PHD SVP OF CLINICAL & PROF AFFAIRS 231288 0 6000 0 0 0 9878 0 21065 0 268231 0 0 0 LAUREL VILLERS CLERK, CHIEF BUSINESS DEVELOPMENT OF 207641 0 4000 0 0 0 8799 0 22312 0 242752 0 0 0 CHERYL SADELI CFO/TREASURER 184513 0 4000 0 0 0 7577 0 3175 0 199265 0 0 0 KLIMENTY LEVIN SOFTWARE ARCHITECT 183969 0 4000 0 0 0 7472 0 2964 0 198405 0 0 0 ALAN KWOK OPTOMETRIST 159841 0 4000 0 0 0 6958 0 22312 0 193111 0 0 0 BITA ASGHARI OPTOMETRIST 150493 0 4000 0 0 0 6191 0 2409 0 163093 0 0 0 CHIRAG PATEL OPTOMETRIST 142118 0 4000 0 0 0 5995 0 9110 0 161223 0 0 0 OLGA TOMASHEVSKAYA DIRECTOR OF ENGINEERING 139712 0 3000 0 0 0 5646 0 3105 0 151463 0 0 0 PART I, LINE 7 BONUSES PAID TO EMPLOYEES ARE DISCRETIONARY. X 3 18242 AVE PRICE ON DAY DONATED X OPTICAL EQUIPMENT 1 22000 FMV 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B UPON RECEIVING DRAFTS FROM OUR CPA FIRM (AUDITORS), BOSTONSIGHT WILL TAKE THE FOLLOWING STEPS TO ASSURE ACCURACY AND COMPLIANCE WITH FEDERAL TAX REGULATIONS. THE PRESIDENT AND CFO OF BOSTONSIGHT WILL REVIEW THE FORM 990 IN DETAIL INCLUDING ACCOUNT GROUPINGS. UPON SATISFACTORY REVIEW, THE BOSTONSIGHT TREASURER WILL SUBMIT THE FORM 990 DRAFT TO THE BOSTONSIGHT AUDIT COMMITTEE. THE CPA FIRM WILL HOLD A MEETING FOR THE AUDIT COMMITTEE TO ADDRESS ANY CONCERNS OR QUESTIONS. UPON SATISFACTORY REVIEW BY THE AUDIT COMMITTEE, THE FINAL FORM 990 WILL BE GENERATED BY THE CPA FIRM. THE FINAL COPY OF THE FORM 990 WILL BE EMAILED TO ALL BOARD MEMBERS BEFORE FILING. FORM 990, PART VI, SECTION B, LINE 12C WE REQUIRE BOSTONSIGHT DIRECTORS, OFFICERS, AND KEY EMPLOYEES TO SIGN A CONFLICT OF INTEREST ACKNOWLEDGEMENT AND DISCLOSURE STATEMENT ANNUALLY. THE CEO AND CFO REVIEW THE FORMS AND DETERMINE IF A POTENTIAL CONFLICT EXISTS. ANY INDIVIDUAL THAT HAS A CONFLICT IS RECUSED FROM DISCUSSION AND VOTING ON THE GIVEN TOPIC. FORM 990, PART VI, SECTION B, LINE 15A THE CEO'S COMPENSATION WAS REVIEWED BY AN INDEPENDENT CONSULTANT. FORM 990, PART VI, SECTION C, LINE 19 THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND AUDITED FINANCIAL STATEMENTS ARE AVAILABLE FROM THE ORGANIZATION UPON REQUEST. THE FORM 990 AND AUDITED FINANCIAL STATEMENTS ARE AVAILABLE VIA THE MASSACHUSETTS ATTORNEY GENERAL'S WEBSITE. THE FORM 990 IS ALSO AVAILABLE AT WWW.GUIDESTAR.ORG. FORM 990, PART XII, LINE 2C BOSTONSIGHT HAS NOT CHANGED ITS OVERSIGHT AND SELECTION PROCESS FROM THE PRIOR YEAR. BOSTONSIGHT SPECIALTY LENSES INC 464 HILLSIDE AVE SUITE 205 NEEDHAM MA 02494 832514718 MANUFACTURING MEDICAL DEVICES MA THE BOSTON FOUNDATION FOR SIGHT C 3312183 -663821 1.00000 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 BOSTONSIGHT SPECIALTY LENSES INC Q 3046413 INTERCOMPANY REVENUE/EXPENSES BOSTONSIGHT SPECIALTY LENSES INC D 1008436 AMOUNT DUE FROM SPECIALTY LENSES